GRL Pharma Private Limited
About GRL Pharma Private Limited
Data last updated:
GRL Pharma Private Limited is a private limited company based in Thrissur, Kerala, India. It was incorporated on 20 October 2023.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U46497KL2023PTC084158.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mangalam Krishnan Sachidanandan and Mundangattil Rahul Raju (Individual Subscriber).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Room No. 8/520 – 5 Pck Building, Vilvattam Nellikkad Thrissur, Kerala, India – 680631.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.09 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹15.92 Lakh (net margin -7.6%) and EBITDA of -₹14.06 Lakh (EBITDA margin -6.7%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRoom No. 8/520 – 5 Pck Building, Vilvattam Nellikkad Thrissur, Kerala, India – 680631
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of GRL Pharma Private Limited
The main business activity of GRL Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of GRL Pharma Private Limited FY 2025 filings available
GRL Pharma Private Limited reported revenue of ₹2.09 Cr (up 350% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of GRL Pharma Private Limited
Revenue rose 350% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of GRL Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹14.06 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹15.92 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of GRL Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -6.7% | •••• |
| Net Profit Margin | -7.6% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of GRL Pharma are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of GRL Pharma Private Limited
GRL Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Its own revenue is ₹2.09 Cr.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mediere Pharmaceuticals Private Limited | ₹2.1 Cr | ₹47.4 Lakh | -23% | 39 | Nahan, Himachal Pradesh, India | |
| Karsy Health Care Private Limited | ₹2.1 Cr | ₹9.51 Lakh | 5% | +42% | Bangalore, Karnataka, India | |
| Spycaa Life Care Sciences Private Limited | ₹2.1 Cr | ₹2.58 Lakh | 1% | +14% | Maduranthakam, Tamil Nadu, India | |
| Proneness Pharmaceuticals Private Limited | ₹2.09 Cr | ₹7.68 Lakh | 4% | +38% | Lucknow, Uttar Pradesh, India | |
| Priska Pharma Private Limited | ₹2.09 Cr | ₹76.69 Lakh | 37% | +36% | New, Delhi, India | |
| GRL Pharma Private Limited this company | ₹2.09 Cr | ₹15.92 Lakh | -7.6% | Thrissur, Kerala, India | ||
| Jenome Biophar Private Limited | ₹2.09 Cr | ₹35.84 Lakh | -17% | -50% | 1 | New, Delhi, India |
| Zydus Technologies Limited | ₹2.09 Cr | ₹10.87 Cr | -520% | Ahmedabad, Gujarat, India | ||
| Magna Cable Manufacturing Private Limited | ₹2.09 Cr | ₹11,763 | 0% | +20% | Delhi, India | |
| MJ Lab Private Limited | ₹2.09 Cr | ₹11,686 | 0% | +11% | Mumbai, Maharashtra, India | |
| Knight Pharmaceuticals Private Limited | ₹2.09 Cr | ₹2.87 Lakh | 1% | +1% | 14 | Virar, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below GRL Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Figures are as filed with the Ministry of Corporate Affairs or the stock exchanges.
Board of Directors of GRL Pharma Private Limited
GRL Pharma has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mangalam Krishnan Sachidanandan | Director | 20 Oct 2023 | 2 Years 11 Months | Current |
| Mundangattil Rahul Raju | Individual Subscriber | 20 Oct 2023 | 2 Years 11 Months | Current |
| Binu Kozhimannil Mathew | Individual Subscriber | 20 Oct 2023 | 2 Years 11 Months | Current |
| Chandrasekharan Hemalatha Anush | Individual Subscriber | 20 Oct 2023 | 2 Years 11 Months | Current |
Charges & Borrowings of GRL Pharma Private Limited
GRL Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at GRL Pharma Private Limited
Employment history and EPFO contributions of people linked to GRL Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on GRL Pharma Private Limited
GRL Pharma Private Limited has 8 board changes on record since 2023: 4 appointments and 4 cessations. The latest: Binu Kozhimannil Mathew ceased to be Additional Director on 30 Dec 2024.
Credit Ratings, Litigation & Regulatory Alerts for GRL Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by GRL Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of GRL Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of GRL Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of GRL Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GRL Pharma Private Limited
GRL Pharma is an active private limited company based in Thrissur, Kerala, India. It was incorporated on 20 October 2023 (3+ years old) and is registered under CIN U46497KL2023PTC084158.
GRL Pharma reported revenue of ₹2.09 Cr for FY 2025 (up 350% YoY).
GRL Pharma has 4 current directors:
- Mangalam Krishnan Sachidanandan - Director
- Mundangattil Rahul Raju - Individual Subscriber
- Binu Kozhimannil Mathew - Individual Subscriber
- Chandrasekharan Hemalatha Anush - Individual Subscriber
GRL Pharma reported a net loss of ₹15.92 Lakh (net margin -7.6%) and EBITDA of -₹14.06 Lakh (EBITDA margin -6.7%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of GRL Pharma is U46497KL2023PTC084158. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
GRL Pharma was incorporated on 20 October 2023, making it 3+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of GRL Pharma by revenue are Mediere Pharmaceuticals Private Limited, Karsy Health Care Private Limited, Spycaa Life Care Sciences Private Limited, Proneness Pharmaceuticals Private Limited, Priska Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Binu Kozhimannil Mathew ceased to be Additional Director on 30 Dec 2024. Chandrasekharan Hemalatha Anush ceased to be Additional Director on 30 Dec 2024. Mundangattil Rahul Raju ceased to be Additional Director on 30 Dec 2024. GRL Pharma has 8 board changes on record in total.
The registered office of GRL Pharma is at Room No. 8520 – 5 Pck Building, Vilvattam Nellikkad Thrissur, Kerala, India – 680631.
GRL Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
No. GRL Pharma is not listed on any stock exchange. It is an unlisted company.